SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-038984
Filing Date
2020-11-24
Accepted
2020-11-24 13:13:06
Documents
5
Period of Report
2020-11-23

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea130376-6k_therapixbio.htm 6-K 17580
2 PLACEMENT AGENCY AGREEMENT, DATED NOVEMBER 19, 2020, BY AND BETWEEN THE COMPANY ea130376ex1-1_therapixbio.htm EX-1.1 92676
3 WARRANT AGENT AGREEMENT, DATED NOVEMBER 23, 2020, BY AND BETWEEN THERAPIX BIOSCI ea130376ex4-1_therapixbio.htm EX-4.1 62578
4 FORM OF WARRANT ea130376ex4-2_therapixbio.htm EX-4.2 102934
5 PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON NOVEMBER 19, 2020 ea130376ex99-1_therapixbio.htm EX-99.1 7619
  Complete submission text file 0001213900-20-038984.txt   284368
Mailing Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608
Business Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 201341948
SIC: 2834 Pharmaceutical Preparations